These data indicate that at least anti-IFNα2 and anti-IFNω IgG autoantibodies are present at the physiological sites of SARS-CoV-2 replication (i.e., the trachea) where they are most likely to exert functional relevance during infection. This evidence concerns the gene IFNA2 and infection.